How Has the Corticosteroids Market Evolved Historically and What is its Current Size?
The corticosteroids market has seen considerable growth due to a variety of factors.
• The market for corticosteroids has been experiencing a stable increase in size over the past few years. The expectations hint at an expansion from $5.47 billion in 2024 to $5.7 billion in 2025, maintaining a compound annual growth rate (CAGR) of 4.1%.
Aspects that contributed to the growth during the historic period include its use in therapy for inflammation, autoimmune diseases and to suppress the immune system, in managing respiratory conditions and asthma, in responding to allergic reactions and in dermatology, and in supporting cancer treatment.
What Is The Projected Growth Of The Corticosteroids Template Market?
The corticosteroids market is expected to maintain its strong growth trajectory in upcoming years.
• The market for corticosteroids is projected to experience significant expansion in the upcoming years, ballooning to a value of $7.24 billion in 2029, progressing at an annual compound growth rate of 6.2%.
Factors contributing to this anticipated growth during the prediction period include increased occurrences of chronic conditions, the widening scope for use in rheumatology, advancements in medication delivery, the rising aging population, and advancements in corticosteroid therapeutics research. Key trends for the prediction period are an emphasis on immunomodulatory effects, growth of the biosimilar market, the progression of combination therapies, the creation of pediatric-specific formulations, and a concentration on regulatory compliance.
What Are The Key Drivers Fueling Growth In The Corticosteroids Market?
The escalating need for cancer therapy is set to boost the advancement of the corticosteroid market. Cancer therapy comprises several treatments like surgery, chemotherapy, radiation therapy, immunotherapy, and targeted treatments, all intended to destroy cancer cells and mitigate symptoms. The burgeoning requirement for cancer therapy is propelled by numerous elements, such as increased cancer instances, heightened awareness and screening, better access to healthcare, and the presence of supportive care services. Cortex-based steroids serve to minimize symptoms and increase the tolerance of cancer treatments, thereby contributing to superior patient results and endorsing the escalating requirement for all-inclusive cancer care. For instance, in May 2024, the National Health Service (NHS) of the UK reported that treatment activity had hit unprecedented levels, with over 1,400 patients beginning their cancer therapy each business day. Between April 2023 and March 2024, close to 340,000 individuals received their introductory cancer treatment. Hence, the escalating need for cancer therapy bolsters the advancement of the corticosteroid market.
What Are The Principal Market Segments In The Global Corticosteroids Industry?
The corticosteroids market covered in this report is segmented –
1) By Product: Glucocorticoids, Mineralocorticoids
2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications
3) By End User: Hospitals, Clinics, Research Institutes, Other End Users
Subsegments:
1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids
2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids
Pre-Book The Corticosteroids Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Corticosteroids Market?
One of the principal trends in the corticosteroid therapy market is the advancement in silicones for topical and transdermal drug delivery. Silicone gel sheets are pliable covers for wounds, featuring cross-linked polymers that are strengthened or adhered to a mesh or fabric. Recently, a novel method has been developed using silicone implants loaded with dexamethasone (DXM) to deliver drugs to the inner ear and assess the drug's dispersion in the cochlea through confocal microscopy. There has also been development of a new device intended for local corticosteroids delivery into the oval window, which provides an extended release of DXM to the inner ear. For younger patients who may not be able to tolerate intralesional corticosteroid injections, silicone gel sheeting serves as an excellent alternative. Transdermal drug delivery with silicone-based pressure-sensitive adhesives has been shown to increase diffusion and enhance skin permeation rates. Silicones provide several benefits including enhanced drug permeability, high diffusivity, and heightened effectiveness in modern drug products.
Who Are the Key Players In The Corticosteroids Market?
Major companies operating in the corticosteroids market include:
• McKesson Corporation
• Pfizer Inc.
• Johnson and Johnson Services Inc.
• Merck & Co.Inc.
• Bayer AG
• Sumitomo Corporation
• Novartis International AG.
• Sanofi SA
• Bristol Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Sun Pharmaceutical Industries Ltd.
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• Endo International plc
• Lupin Limited
• Mallinckrodt Pharmaceuticals Ltd.
• LEO Pharma A/S
• Glenmark Pharmaceuticals Ltd.
• Wockhardt Limited
• Indivior plc
• Zizhu Pharmaceutical Co. Ltd.
• Allergan plc
• Hikma Pharmaceuticals plc
What Are The Regional Insights Into The Corticosteroids Market?
North America was the largest region in the corticosteroids therapy market share in 2024. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
